How Can Optimization of Medical Treatment Avoid Unnecessary Implantable Cardioverter-Defibrillator Implantations in Patients With Idiopathic Dilated Cardiomyopathy Presenting With “SCD-HeFT Criteria?”
The American Journal of Cardiology,

Zecchin M et al. – Two thirds of patients with idiopathic dilated cardiomyopathy and “Sudden Cardiac Death in Heart Failure Trial (SCD–HeFT) criteria,” at presentation did not maintain implantable cardioverter–defibrillator indications 3 to 9 months later with optimal medical therapy. Their long–term outcome was excellent, similar to that observed for patients who had never met the “SCD–HeFT criteria.”

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Cardiology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Cardiology Articles

Indexed Journals in Cardiology: American Heart Journal, American Journal of Cardiology, Circulationn, Heartmore